Form D · Other
bioProtonics, Inc.
Santa Barbara, CA · CIK 0001759133
Offering snapshot reported Apr 9, 2026 · SEC filing
- Reported sold
- $1.02M Offering amount: $2.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 24, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$150,000 → $1,015,000
- Reported investors1 → 6
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 9, 2026 | Amendment | $1,015,000 | $865,000vs Jul 25, 2025 | 6 | SEC filing |
| Jul 25, 2025 | Initial | $150,000 | No comparison | 1 | SEC filing |
| Dec 31, 2024 | Initial | $2,701,248 | No comparison | 18 | SEC filing |
| Apr 10, 2024 | Amendment | $1,893,126 | $1,140,000vs Sep 20, 2023 | 13 | SEC filing |
| Sep 20, 2023 | Amendment | $753,126 | $0vs Sep 12, 2023 | 7 | SEC filing |
| Sep 12, 2023 | Amendment | $753,126 | $550,000vs Sep 15, 2022 | 7 | SEC filing |
| Apr 21, 2023 | Initial | $74,415 | No comparison | 1 | SEC filing |
| Jan 18, 2023 | Initial | $108,900 | No comparison | 3 | SEC filing |
| Sep 15, 2022 | Initial | $203,126 | No comparison | 2 | SEC filing |
| Aug 10, 2021 | Initial | $1,048,785 | No comparison | Not reported | SEC filing |
| Jul 1, 2021 | Amendment | $836,952 | No comparison | Not reported | SEC filing |
| Mar 19, 2021 | Initial | $576,952 | No comparison | 4 | SEC filing |
| Mar 19, 2021 | Amendment | $576,952 | $400,000vs Mar 25, 2020 | 4 | SEC filing |
| Mar 25, 2020 | Initial | $176,952 | No comparison | 2 | SEC filing |
| Mar 25, 2020 | Initial | $594,527 | No comparison | 5 | SEC filing |
| Jan 9, 2020 | Amendment | $781,987 | $0vs Jul 25, 2019 | 4 | SEC filing |
| Jul 25, 2019 | Amendment | $781,987 | $0vs Mar 7, 2019 | 4 | SEC filing |
| Mar 7, 2019 | Initial | $781,987 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-552761
Convertible Notes & Warrants
Source: Form D, filed Apr 9, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott Cannizzaro | Director, Executive |
| Chris Corpuz | Executive |
| Daniel R Doioron | Director, Executive |
| Daniel R. Doiron | Director, Executive |
| Forrest Fleming | Director, Executive |
| Timothy W. James | Director |
| W. Timothy James | Director |
| Kristin Loomis | Director |
| Ryan Shields | Director |
| A. Burton Tripathi | Director, Executive |
| Charles W. Winckler | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
27 W. Anapamu St., Ste. 353
Santa Barbara, CA, 93101
Santa Barbara, CA, 93101